Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Equity Ratio (2016 - 2025)

Guided Therapeutics' Equity Ratio history spans 16 years, with the latest figure at 4.53 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 27.73% to 4.53 in Q4 2025 year-over-year; TTM through Dec 2025 was 4.53, a 27.73% decrease, with the full-year FY2025 number at 4.53, down 27.73% from a year prior.
  • Equity Ratio hit 4.53 in Q4 2025 for Guided Therapeutics, up from 6.31 in the prior quarter.
  • Over the last five years, Equity Ratio for GTHP hit a ceiling of 0.68 in Q3 2022 and a floor of 6.31 in Q3 2025.
  • Historically, Equity Ratio has averaged 3.22 across 5 years, with a median of 3.47 in 2021.
  • Biggest five-year swings in Equity Ratio: surged 89.14% in 2021 and later plummeted 183.95% in 2023.
  • Tracing GTHP's Equity Ratio over 5 years: stood at 2.67 in 2021, then skyrocketed by 67.91% to 0.86 in 2022, then plummeted by 166.25% to 2.28 in 2023, then tumbled by 55.58% to 3.55 in 2024, then decreased by 27.73% to 4.53 in 2025.
  • Business Quant data shows Equity Ratio for GTHP at 4.53 in Q4 2025, 6.31 in Q3 2025, and 5.82 in Q2 2025.